The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway
Open Access
- 1 November 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (45) , 35345-35352
- https://doi.org/10.1074/jbc.m005510200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.Diabetes, 2000
- Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.Diabetes, 1999
- The Glucagon-Like PeptidesEndocrine Reviews, 1999
- Glucagon-like Peptide 2Trends in Endocrinology & Metabolism, 1999
- Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umeå +/?)*Endocrinology, 1999
- Glucagon-Like PeptidesDiabetes, 1998
- Inhibition of polyamine synthesis influences contractility of intestinal smooth muscle in culture.American Journal of Physiology-Cell Physiology, 1997
- Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IVNature Biotechnology, 1997
- Density-dependent proliferation of adult rat hepatocytes in primary culture induced by epidermal growth factor is potentiated by cAMP-elevating agentsEuropean Journal of Pharmacology, 1997
- Induction of intestinal epithelial proliferation by glucagon-like peptide 2.Proceedings of the National Academy of Sciences, 1996